Trinity Delta view: The Jazz milestone is a welcome boost to recently enlarged cash resources but, more importantly, is further tangible evidence of the progress being achieved across a broad front. Redx Pharma has always sought to maximise the value of its discovery programmes, but with the inherent risks managed actively. This has resulted in a well-balanced clinical pipeline, with a mix of in-house and partnered programmes. It is the expected progress from these that should provide a stream of news flow over the next 12-18 months. We view May’s impressive equity raise as a testament to the strength of the investment case, which supports a wider appreciation of the equity story. Our rNPV model is currently under review following this placing and we will issue a revised valuation as soon as practicable.
15 Jun 2022
Trinity Delta Lighthouse: Redx Pharma
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Trinity Delta Lighthouse: Redx Pharma
Redx Pharma Plc (REDX:LON), 18.5 | Redx Pharma Plc (REDX:LON), 18.5
- Published:
15 Jun 2022 -
Author:
Franc Gregori | Lala Gregorek | Philippa Gardner -
Pages:
2
Trinity Delta view: The Jazz milestone is a welcome boost to recently enlarged cash resources but, more importantly, is further tangible evidence of the progress being achieved across a broad front. Redx Pharma has always sought to maximise the value of its discovery programmes, but with the inherent risks managed actively. This has resulted in a well-balanced clinical pipeline, with a mix of in-house and partnered programmes. It is the expected progress from these that should provide a stream of news flow over the next 12-18 months. We view May’s impressive equity raise as a testament to the strength of the investment case, which supports a wider appreciation of the equity story. Our rNPV model is currently under review following this placing and we will issue a revised valuation as soon as practicable.